Industry Expertise

Axiom is committed to the success of your study. We have dedicated 20 years accelerating studies for small-to-mid size life science companies across the globe, in over 30 specialized therapeutic areas, from pre-clinical to post-marketing phases.

Your study is unique. Find out how Axiom can help.

Connect with us about your unique study needs!

Key Industry Sectors

We are a partner of choice for biotech, device companies, and CROs.
LEARN MORE

30+ Therapeutic Areas

We take pride in our broad range of experience in specialty research.
LEARN MORE

All Research Phases

Fusion has powered studies from pre-clinical to Phase IV and post-marketing.
LEARN MORE

Axiom works with Clients on Studies across the globe.


Industry Sectors

Axiom delivers an easy to use & cost-effective unified eClinical solution that is both robust and flexible enough to meet the needs and budgets of start up companies as well as established, growing organizations across industry sectors.

Biotech and Pharma

Axiom is the trusted partner of small-to-medium biotech and pharma organizations around the world doing critical research in a diverse number of specialized fields.

Learn More

Devices and Diagnostics

Axiom is a dedicated partner to small-to-medium device and diagnostics companies looking to revolutionize health tech.

Learn More

Contract Research Organizations

Axiom is an efficient and cost-effective partner to CROs. Our powerful Fusion eClinical Suite is a highly configurable unified eClinical solution that can effectively meet the unique needs of any CRO and for the Sponsor Trials they are leading.

Connect with Us!

Therapeutic Areas

Axiom got its start in complex transplant studies and has remained focused on supporting the advancement of specialty research with our powerful Fusion eClinical Suite, in addition to our Data Management, Pharmacovigilance, and Biostats services. We now have experience delivering studies in over 30 Therapeutic Areas.

Have a specialty research study in mind?

Specialty Research

  • Autoimmune Disorders
  • Cardiology
  • CNS / Neurology
  • Dermatology
  • Endocrinology
  • Gastrointestinal
  • Genitourinary
  • Haematology
  • HIV
  • Infectious Diseases
  • Musculoskeletal
  • Oncology
  • Ophthalmology
  • Pain Management
  • Rare Diseases
  • Respiratory
  • Rheumatology
  • Transplant
  • Urology
  • Women’s Health
  • …and more!

Device Studies

  • Aneurysm Treatments
  • Dental Implants
  • External Devices
  • Medication Delivery
  • Osteoarthritis
  • Pain Management
  • Peripheral Devices
  • Prostatic Hyperplasia
  • Stroke-related

Over 200 device studies completed, including peripheral and external devices!

Research Phases

Axiom is the partner of choice for small to medium life sciences organizations. Our unified Fusion eClinical Suite has powered research from pre-clinical studies to global trials and registries in more than 40 countries.

Getting ready for the next phase of your study?

Research Phase Breakdown: Drug Studies

  • Phase I Studies – 27%
  • Phase II Studies – 23%
  • Phase III Studies – 18%
  • Phase IV / Registry – 24%
  • Post-Marketing Services – 8%

Research Phase Breakdown: Device Studies

  • Phase I Studies – 20%
  • Phase II Studies – 23%
  • Phase III Studies – 28%
  • Phase IV / Registry – 21%
  • Post-Marketing Services – 8%

Your study is unique. Find out how Axiom can help!

Driving Collaboration via Real-Time Actionable Data: Axiom’s Fusion platform eliminates the labor-intensive manual tasks so often required by small-to-mid size companies in managing a clinical study or study platform.